{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,8,18]],"date-time":"2023-08-18T23:45:17Z","timestamp":1692402317458},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2016,6,18]],"date-time":"2016-06-18T00:00:00Z","timestamp":1466208000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Cardiol Rep"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1007\/s11886-016-0746-5","type":"journal-article","created":{"date-parts":[[2016,6,18]],"date-time":"2016-06-18T08:31:47Z","timestamp":1466238707000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Use of the Wearable Cardioverter Defibrillator in High-Risk Populations"],"prefix":"10.1007","volume":"18","author":[{"given":"Madhab","family":"Lamichhane","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdul","family":"Safadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phani","family":"Surapaneni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Negar","family":"Salehi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ranjan K.","family":"Thakur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,6,18]]},"reference":[{"key":"746_CR1","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1056\/NEJM198008073030607","volume":"303","author":"M Mirowski","year":"1980","unstructured":"Mirowski M, Reid PR, Mower MM, et al. Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings. N Engl J Med. 1980;303:322\u20134.","journal-title":"N Engl J Med"},{"key":"746_CR2","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jacc.2008.02.032","volume":"51","author":"AE Epstein","year":"2008","unstructured":"Epstein AE, DiMarco JP, Ellenbogen KA, et al. ACC\/AHA\/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC\/AHA\/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. J Am Coll Cardiol. 2008;51:e1\u201362.","journal-title":"J Am Coll Cardiol"},{"key":"746_CR3","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1161\/CIR.0000000000000152","volume":"131","author":"D Mozaffarian","year":"2015","unstructured":"Mozaffarian D, Benjamin EJ, Go AS, et al. Heart disease and stroke statistics\u20142015 update: a report from the American Heart Association. Circulation. 2015;131:e29\u2013322.","journal-title":"Circulation"},{"key":"746_CR4","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1001\/jama.300.12.1423","volume":"300","author":"G Nichol","year":"2008","unstructured":"Nichol G, Thomas E, Callaway CW, et al. Regional variation in out-of-hospital cardiac arrest incidence and outcome. JAMA. 2008;300:1423\u201331.","journal-title":"JAMA"},{"key":"746_CR5","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1161\/CIRCULATIONAHA.112.123588","volume":"126","author":"L Ilkhanoff","year":"2012","unstructured":"Ilkhanoff L, Goldberger JJ. Out-of-hospital cardiac arrest: getting beyond the tip of the iceberg. Circulation. 2012;126:793\u20136.","journal-title":"Circulation"},{"key":"746_CR6","unstructured":"U.S. Food and Drug Administration. Summary of Safety and Effectiveness Data, PO100300 Lifecor, Inc. WCD 2000 System. 2001. http:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf\/p010030b.Pdf"},{"key":"746_CR7","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jelectrocard.2009.05.010","volume":"43","author":"KA Dillon","year":"2010","unstructured":"Dillon KA, Szymkiewicz SJ, Kaib TE. Evaluation of the effectiveness of a wearable cardioverter defibrillator detection algorithm. J Electrocardiol. 2010;43:63\u20137.","journal-title":"J Electrocardiol"},{"key":"746_CR8","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1046\/j.1460-9592.2003.00311.x","volume":"26","author":"S Reek","year":"2003","unstructured":"Reek S, Geller JC, Meltendorf U, et al. Clinical efficacy of a wearable defibrillator in acutely terminating episodes of ventricular fibrillation using biphasic shocks. Pacing Clin Electrophysiol. 2003;26:2016\u201322.","journal-title":"Pacing Clin Electrophysiol"},{"key":"746_CR9","doi-asserted-by":"crossref","unstructured":"Feldman AM, Klein H, Tchou P, et al. Use of a wearable defibrillator in terminating tachyarrhythmias in patients at high risk for sudden death: results of the WEARIT\/BIROAD. Pacing Clin Electrophysiol. 2004;27:4\u20139.","DOI":"10.1111\/j.1540-8159.2004.00378.x"},{"key":"746_CR10","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.jacc.2014.04.008","volume":"64","author":"FM Kusumoto","year":"2014","unstructured":"Kusumoto FM, Calkins H, Boehmer J, et al. HRS\/ACC\/AHA expert consensus statement on the use of implantable cardioverter-defibrillator therapy in patients who are not included or not well represented in clinical trials. J Am Coll Cardiol. 2014;64:1143\u201377.","journal-title":"J Am Coll Cardiol"},{"key":"746_CR11","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ihj.2013.12.050","volume":"66","author":"J Francis","year":"2014","unstructured":"Francis J, Reek S. Wearable cardioverter defibrillator: a life vest till the life boat (ICD) arrives. Indian Heart J. 2014;66:68\u201372.","journal-title":"Indian Heart J"},{"key":"746_CR12","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.ahj.2005.05.015","volume":"151","author":"DM Henkel","year":"2006","unstructured":"Henkel DM, Witt BJ, Gersh BJ, et al. Ventricular arrhythmias after acute myocardial infarction: a 20-year community study. Am Heart J. 2006;151:806\u201312.","journal-title":"Am Heart J"},{"key":"746_CR13","doi-asserted-by":"crossref","first-page":"e002460","DOI":"10.1161\/CIRCHEARTFAILURE.115.002460","volume":"9","author":"Y Gerber","year":"2016","unstructured":"Gerber Y, Weston SA, Enriquez-Sarano M, et al. Mortality associated with heart failure after myocardial infarction: a contemporary community perspective. Circ Heart Fail. 2016;9:e002460.","journal-title":"Circ Heart Fail"},{"key":"746_CR14","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.ejim.2014.08.009","volume":"25","author":"A Gjesing","year":"2014","unstructured":"Gjesing A, Gislason GH, Kober L, et al. Nationwide trends in development of heart failure and mortality after first-time myocardial infarction 1997\u20132010: a Danish cohort study. Eur J Intern Med. 2014;25:731\u20138.","journal-title":"Eur J Intern Med"},{"key":"746_CR15","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1056\/NEJM199612263352601","volume":"335","author":"AJ Moss","year":"1996","unstructured":"Moss AJ, Hall WJ, Cannom DS, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med. 1996;335:1933\u201340.","journal-title":"N Engl J Med"},{"key":"746_CR16","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJMoa013474","volume":"346","author":"AJ Moss","year":"2002","unstructured":"Moss AJ, Zareba W, Hall WJ, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346:877\u201383.","journal-title":"N Engl J Med"},{"key":"746_CR17","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJMoa043399","volume":"352","author":"GH Bardy","year":"2005","unstructured":"Bardy GH, Lee KL, Mark DB, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005;352:225\u201337.","journal-title":"N Engl J Med"},{"key":"746_CR18","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1056\/NEJM199912163412503","volume":"341","author":"AE Buxton","year":"1999","unstructured":"Buxton AE, Lee KL, Fisher JD, et al. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med. 1999;341:1882\u201390.","journal-title":"N Engl J Med"},{"key":"746_CR19","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1056\/NEJMoa041489","volume":"351","author":"SH Hohnloser","year":"2004","unstructured":"Hohnloser SH, Kuck KH, Dorian P, et al. Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. N Engl J Med. 2004;351:2481\u20138.","journal-title":"N Engl J Med"},{"key":"746_CR20","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1056\/NEJMoa0901889","volume":"361","author":"G Steinbeck","year":"2009","unstructured":"Steinbeck G, Andresen D, Seidl K, et al. Defibrillator implantation early after myocardial infarction. N Engl J Med. 2009;361:1427\u201336.","journal-title":"N Engl J Med"},{"key":"746_CR21","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1056\/NEJM199711273372201","volume":"337","author":"JT Bigger Jr","year":"1997","unstructured":"Bigger Jr JT. Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery. Coronary Artery Bypass Graft (CABG) Patch Trial Investigators. N Engl J Med. 1997;337:1569\u201375.","journal-title":"N Engl J Med"},{"key":"746_CR22","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1007\/s00392-002-0874-3","volume":"91","author":"S Reek","year":"2002","unstructured":"Reek S, Meltendorf U, Geller JC, et al. The wearable cardioverter defibrillator (WCD) for the prevention of sudden cardiac death\u2014a single center experience. Z Kardiol. 2002;91:1044\u201352.","journal-title":"Z Kardiol"},{"key":"746_CR23","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.jacc.2010.04.016","volume":"56","author":"MK Chung","year":"2010","unstructured":"Chung MK, Szymkiewicz SJ, Shao M, et al. Aggregate national experience with the wearable cardioverter-defibrillator: event rates, compliance, and survival. J Am Coll Cardiol. 2010;56:194\u2013203.","journal-title":"J Am Coll Cardiol"},{"key":"746_CR24","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/j.1540-8159.2009.02590.x","volume":"33","author":"HU Klein","year":"2010","unstructured":"Klein HU, Meltendorf U, Reek S, et al. Bridging a temporary high risk of sudden arrhythmic death. Experience with the wearable cardioverter defibrillator (WCD). Pacing Clin Electrophysiol. 2010;33:353\u201367.","journal-title":"Pacing Clin Electrophysiol"},{"key":"746_CR25","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1161\/CIRCEP.112.973552","volume":"6","author":"ET Zishiri","year":"2013","unstructured":"Zishiri ET, Williams S, Cronin EM, et al. Early risk of mortality after coronary artery revascularization in patients with left ventricular dysfunction and potential role of the wearable cardioverter defibrillator. Circ Arrhythm Electrophysiol. 2013;6:117\u201328. This observational study demonstrates that survivors of coronary artery bypass graft surgery or post percutaneous coronary intervention with low left ventricular ejection fraction \u226435% are at increased risk of mortality and WCD use was associated with lower mortality compared to the non users.","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"746_CR26","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1016\/j.jacc.2013.05.086","volume":"62","author":"AE Epstein","year":"2013","unstructured":"Epstein AE, Abraham WT, Bianco NR, et al. Wearable cardioverter-defibrillator use in patients perceived to be at high risk early post-myocardial infarction. J Am Coll Cardiol. 2013;62:2000\u20137. This study shows that during the waiting period after myocardial infarction the risk of sudden cardiac arrest is highest in the first month and WCD successfully treated sudden cardiac arrest.","journal-title":"J Am Coll Cardiol"},{"key":"746_CR27","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1016\/j.hrthm.2011.06.031","volume":"8","author":"E Hookana","year":"2011","unstructured":"Hookana E, Junttila MJ, Puurunen VP, et al. Causes of nonischemic sudden cardiac death in the current era. Heart Rhythm. 2011;8:1570\u20135.","journal-title":"Heart Rhythm"},{"key":"746_CR28","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.cpcardiol.2015.01.002","volume":"40","author":"VP Kuriachan","year":"2015","unstructured":"Kuriachan VP, Sumner GL, Mitchell LB. Sudden cardiac death. Curr Probl Cardiol. 2015;40:133\u2013200.","journal-title":"Curr Probl Cardiol"},{"key":"746_CR29","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1002\/ejhf.188","volume":"16","author":"D Duncker","year":"2014","unstructured":"Duncker D, Haghikia A, Konig T, et al. Risk for ventricular fibrillation in peripartum cardiomyopathy with severely reduced left ventricular function-value of the wearable cardioverter\/defibrillator. Eur J Heart Fail. 2014;16:1331\u20136. This study shows that peripartum cardiomyopathy patients with reduced ejection are at increased risk of ventricular tachyarrhythmia and WCD prevents sudden cardiac arrest.","journal-title":"Eur J Heart Fail"},{"key":"746_CR30","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1016\/j.jacc.2015.09.079","volume":"66","author":"M Singh","year":"2015","unstructured":"Singh M, Wang NC, Jain S, et al. Utility of the wearable cardioverter-defibrillator in patients with newly diagnosed cardiomyopathy: a decade-long single-center experience. J Am Coll Cardiol. 2015;66:2607\u201313.","journal-title":"J Am Coll Cardiol"},{"key":"746_CR31","doi-asserted-by":"publisher","unstructured":"Salehi N, Nasiri M, Bianco NR et al. The wearable cardioverter-defibrillator in non-ischemic cardiomyopathy: a United States National Data Base analysis. Can J Cardiol. 2016. doi: 10.1016\/j.cjca.2015.12.035.","DOI":"10.1016\/j.cjca.2015.12.035."},{"key":"746_CR32","unstructured":"Deeprasertkul PO, M.; Bianco, B.R.; Salehi, N et al. National experience with wearable cardioverter-defibrillator use in takotsubo cardiomyopathy. The Journal of Innovations in Cardiac Rhythm Management 2014;5:1707\u20131713."},{"key":"746_CR33","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ccep.2015.03.010","volume":"7","author":"MC Honigberg","year":"2015","unstructured":"Honigberg MC, Givertz MM. Arrhythmias in peripartum cardiomyopathy. Card Electrophysiol Clin. 2015;7:309\u201317.","journal-title":"Card Electrophysiol Clin"},{"key":"746_CR34","first-page":"1067","volume":"36","author":"D Duncker","year":"2015","unstructured":"Duncker D, Bauersachs J, Hilfiker-Kleiner D, et al. Underestimated risk for life-threatening ventricular arrhythmias in newly diagnosed peripartum cardiomyopathy? Eur Heart J. 2015;36:1067\u20138.","journal-title":"Eur Heart J"},{"key":"746_CR35","doi-asserted-by":"crossref","unstructured":"Everitt MDV, A.; Saarel, E.V. The wearable external cardiac defibrillator for cancer patients at risk for sudden cardiac death. Community Oncol 2011;8:400-403.","DOI":"10.1016\/S1548-5315(12)70086-4"},{"key":"746_CR36","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s00392-009-0093-2","volume":"99","author":"D Prochnau","year":"2010","unstructured":"Prochnau D, Surber R, Kuehnert H, et al. Successful use of a wearable cardioverter-defibrillator in myocarditis with normal ejection fraction. Clin Res Cardiol. 2010;99:129\u201331.","journal-title":"Clin Res Cardiol"},{"key":"746_CR37","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.healun.2015.04.004","volume":"34","author":"M Opreanu","year":"2015","unstructured":"Opreanu M, Wan C, Singh V, et al. Wearable cardioverter-defibrillator as a bridge to cardiac transplantation: a national database analysis. J Heart Lung Transplant. 2015;34:1305\u20139. This study shows that WCD is reasonable bridge therapy to prevent sudden cardiac arrest while waiting cardiac transplantation.","journal-title":"J Heart Lung Transplant"},{"key":"746_CR38","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1111\/pace.12319","volume":"37","author":"T Tanawuttiwat","year":"2014","unstructured":"Tanawuttiwat T, Garisto JD, Salow A, et al. Protection from outpatient sudden cardiac death following ICD removal using a wearable cardioverter defibrillator. Pacing Clin Electrophysiol. 2014;37:562\u20138. This study shows that WCD provides protection from sudden cardiac arrest when ICD is removed for cardiac device related infections.","journal-title":"Pacing Clin Electrophysiol"},{"key":"746_CR39","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/j.hrthm.2015.03.061","volume":"12","author":"CA Healy","year":"2015","unstructured":"Healy CA, Carrillo RG. Wearable cardioverter-defibrillator for prevention of sudden cardiac death after infected implantable cardioverter-defibrillator removal: a cost-effectiveness evaluation. Heart Rhythm. 2015;12:1565\u201373.","journal-title":"Heart Rhythm"},{"key":"746_CR40","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1161\/CIRCULATIONAHA.115.015677","volume":"132","author":"V Kutyifa","year":"2015","unstructured":"Kutyifa V, Moss AJ, Klein H, et al. Use of the wearable cardioverter defibrillator in high-risk cardiac patients: data from the Prospective Registry of Patients Using the Wearable Cardioverter Defibrillator (WEARIT-II Registry). Circulation. 2015;132:1613\u20139.","journal-title":"Circulation"},{"key":"746_CR41","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1016\/j.amjcard.2011.07.021","volume":"108","author":"M Rao","year":"2011","unstructured":"Rao M, Goldenberg I, Moss AJ, et al. Wearable defibrillator in congenital structural heart disease and inherited arrhythmias. Am J Cardiol. 2011;108:1632\u20138.","journal-title":"Am J Cardiol"}],"container-title":["Current Cardiology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-016-0746-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11886-016-0746-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-016-0746-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,18]],"date-time":"2023-08-18T23:10:44Z","timestamp":1692400244000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11886-016-0746-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,18]]},"references-count":41,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["746"],"URL":"https:\/\/doi.org\/10.1007\/s11886-016-0746-5","relation":{},"ISSN":["1523-3782","1534-3170"],"issn-type":[{"value":"1523-3782","type":"print"},{"value":"1534-3170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,18]]},"article-number":"78"}}